🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Service Reaction and Material Elimination

According to the social media company, the service has removed problematic content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.

After moments of joining one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Information and Costs

Within these communities, messages display black plastic parcels with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram stated it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially significant medical dangers”.